Screening for Colorectal Cancer in Average-Risk Populations

American Journal of Medicine

Volumn 119, Issue 9, 2006, Pages 728-735

  Lieberman, David ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Colonoscopy; Colorectal cancer; Computed tomographic colonography; Fecal occult blood test; Sigmoidoscopy

Indexed keywords

BARIUM ENEMA; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; FECES ANALYSIS; FOLLOW UP; HUMAN; IMMUNOCHEMISTRY; OCCULT BLOOD; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY CONTROL; RACE DIFFERENCE; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SIGMOIDOSCOPY;

COLORECTAL NEOPLASMS; HUMANS; INCIDENCE; MASS SCREENING; RISK FACTORS;

EID: 33747875382     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.03.037     Document Type: Review

References (47)

1. Jemal A., Murray T., Samuels A., et al. Cancer statistics 2005. CA Cancer J Clin 55 (2005) 10-30
2. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329 (1993) 1977-1981
3. Mandel J.S., Church T.R., Bond J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000) 1603-1607
4. Centers for Disease Control and Prevention. Trends in screening for colorectal cancer-United States, 1997 and 1999. MMWR Morb Mortal Wkly Rep 50 (2001) 162-166
5. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124 (2003) 544-560
6. Pignone M., Rich M., Teutsch S.M., Berg A.O., and Lohr K.N. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 132-141
7. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society guidelines for the early detection of cancer 2003. CA Cancer J Clin 53 (2003) 27-43
8. Rex D.K., Johnson D.A., Lieberman D.A., Burt R.W., and Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 95 (2000) 868-877
9. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328 (1993) 1365-1371
10. Hardcastle J.D., Chamberlain J., Robinson M.H.E., et al. Randomized, controlled trial of fecal occult blood screening for colorectal cancer. Lancet 148 (1996) 1472-1477
11. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., and Sondergaard O. Randomized study of screening for colorectal cancer with fecal occult blood test. Lancet 148 (1996) 1467-1471
12. Jorgensen O.D., Kronborg O., and Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50 (2002) 29-32
13. Faivre J., Dancourt V., Lejeune C., et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126 (2004) 1674-1680
14. Lieberman D.A., Weiss D.G., and VA Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345 (2001) 555-560
15. Imperiale T.F., Ransohoff D.E., Itzkowitz S.H., Turnbull B.A., Ross M.E., and Colorectal Cancer Study Group. Fecal DNA vs. fecal occult blood for colorectal cancer screening in an average-risk population. N Engl J Med 351 (2004) 2704-2714
16. Young G.P., St John J.B., Winawer S.J., and Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies. Am J Med 97 (2002) 2499-2507
17. Nadel M.R., Shapiro J.A., Klabunde C.N., et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 142 (2005) 86-94
18. Klabunde C.N., Frame P.S., Meadow A., Jones E., Nadel M., and Vernon S.W. A national survey of primary care physicians' colorectal cancer screening recommendations and practices. Prev Med 36 (2003) 352-362
19. Collins J.F., Lieberman D.A., Durbin T.E., and Weiss D.G. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med 142 (2005) 81-85
20. Cole S.R., and Young G.P. Participation in fecal occult blood test-based screening for colorectal cancer is reduced by dietary restriction. Med J Aust 175 (2001) 195-198
21. Nakama H., Zhang B., and Fattah A.S.M.A. A cost-effective analysis of the optimum number of stool specimens collected for immunochemical occult blood screening for colorectal cancer. Eur J Cancer 36 (2000) 647-650
22. Morikawa T., Kato J., Yamaji Y., Wada Y., Mitsushima T., and Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129 (2005) 422-428
23. Allison J.E., Tekawa I.S., Ransom L.J., and Adrian A.L. A comparison of fecal-occult blood tests for colorectal cancer screening. N Engl J Med 336 (1996) 155-159
24. Selby J.V., Friedman G.D., Quesenberry Jr. C.P., and Weiss N.S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326 (1992) 653-657
25. Newcomb P.A., Norfleet R.G., Storer B.E., Surawicz T.S., and Marcus P.M. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84 (1992) 1572-1575
26. Lieberman D.A., Weiss D.G., Bond J.H., Ahnen D.J., Garewal H., Chejfec G., and VACSP Group #380. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 343 (2000) 162-168
27. Imperiale T.F., Wagner D.R., Lin C.Y., Larkin G.R., Rogge J.D., and Ransohoff D.F. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343 (2000) 169-174
28. Rex D.K., Cummings O.W., Helper D.J., et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology 111 (1996) 1178-1181
29. Doria-Rose V.P., Levin T.R., Selby J.V., Newcomb P.A., Richert-Boe K.E., and Weiss N.S. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology 127 (2004) 714-722
30. Schoen R.E., Pinsky P.F., Weissfeld J.L., et al., PLCO Group. Results of repeat sigmoidoscopy 3 years after a negative sigmoidoscopy. JAMA 290 (2003) 41-48
31. Ashley O.S., Nadel M., and Ransohoff D.F. Achieving quality in flexible sigmoidoscopy screening for colorectal cancer. Am J Med 111 (2001) 643-653
32. Atkin W., Rogers P., Cardwell C., et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology 126 (2004) 1247-1256
33. Winawer S.J., Stewart E.T., Zauber A.G., et al., NPS Workgroup. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med 342 (2000) 1766-1772
34. Cotton P.B., Durkalski V.L., Pineau B.C., et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasms. JAMA 291 (2004) 1713-1719
35. Rockey D.C., Paulson E., Niedzwiecki D., et al. Analysis of air contrast barium enema, computed tomographic colonography and colonoscopy: prospective comparison. Lancet 365 (2005) 305-311
36. Pickhardt P.J., Choi R., Hwang I., et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349 (2003) 2191-2200
37. Johnson C.D., Harmsen W.S., Wilson L.A., et al. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology 125 (2003) 311-319
38. Brenner D.J., and Georgsson M.A. Mass screening with CT colonography: should the radiation exposure be of concern?. Gastroenterology 129 (2005) 328-337
39. Schoenfeld P., Cash B., Flood A., et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 352 (2005) 2061-2068
40. Muller A.D., and Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: a case-control study of 32 702 Veterans. Ann Intern Med 123 (1995) 904-910
41. Schatzkin A., Lanza E., Corle D., et al., Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 342 (2000) 1149-1155
42. Alberts D.S., Martinez M.E., Roe D.J., et al., Phoenix Colon Cancer Prevention Physicians Network. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 342 (2000) 1156-1162
43. Robertson D.J., Greenberg E.R., Beach M., et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 129 (2005) 34-41
44. Imperiale T.F., Rogge J.D., Glowinski E.Z., Lin-Cooper C.Y., Larkin G.N., and Ransohoff D.F. Five year risk of colorectal neoplasia among persons with no neoplasia on baseline screening colonoscopy. Gastroenterology 126 (2004) A36
45. Nelson D.B., McQuaid K.R., Bond J.H., et al. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 55 (2002) 307-314
46. Rex D.K., Bond J.H., Winawer S., et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society task force on colorectal cancer. Am J Gastroenterol 97 (2002) 1296-1308
47. Agrawal S., Bhupinderjit A., Bhutani M.S., et al. Colorectal cancer in African Americans. Am J Gastroenterol 100 (2005) 515-523